L
The startup has developed a transdermal naltrexone patch that delivers the medication through the skin, providing an alternative to oral tablets and intramuscular injections. This method reduces the common side effects associated with traditional naltrexone formulations, facilitating more effective management of opioid addiction and alcohol use disorder.
Edinburgh, United Kingdom
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a transdermal naltrexone patch that delivers the medication through the skin, providing an alternative to oral tablets and intramuscular injections. This method reduces the common side effects associated with traditional naltrexone formulations, facilitating more effective management of opioid addiction and alcohol use disorder.